Hillsdale Investment Management’s Apollo Endosurgery, Inc. APEN Stock Holding History

Hillsdale Investment Management’s Portfolio APEN Stock Details APEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-218,721	Closed	-$1.84M	–	636
2021 Q4	$1.84M	Sell	218,721 -41,000	-16%	-$358K	0.12%	171
2021 Q3	$2.35M	Buy	259,721 +45,070	+21%	+$388K	0.18%	151
2021 Q2	$1.74M	Buy	+214,651	New	+$1.47M	0.14%	163

Other funds holding APEN

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

Hillsdale Investment Management's APEN Position: Q1 2022 in Review

Hillsdale Investment Management sold out of Apollo Endosurgery, Inc. (APEN) in Q1 2022, closing a stake of 218,721 shares — an estimated $1.84M sold.

Hillsdale Investment Management first reported a position in APEN in Q2 2021 and held it in 3 quarters. The position peaked at $2.35M in Q3 2021. 71 funds tracked by Wall St. Rank hold APEN as of Q1 2022.

Hillsdale Investment Management reported no remaining Apollo Endosurgery, Inc. position as of Q1 2022 after selling out during the quarter.
Hillsdale Investment Management sold 218,721 Apollo Endosurgery, Inc. shares in Q1 2022, an estimated $1.84M.
Hillsdale Investment Management first reported a position in Apollo Endosurgery, Inc. in Q2 2021 and held it in 3 quarters.
Hillsdale Investment Management's Apollo Endosurgery, Inc. position peaked at $2.35M in Q3 2021.
71 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q1 2022.

Based on Hillsdale Investment Management's 13F filing for Q1 2022, filed 28 Apr 2022.